Intrinsiqq
BridgeBio Oncology Therapeutics, Inc. logo

BridgeBio Oncology Therapeutics, Inc. Insider Trading

BBOT

Compare
Last 12 months

Insiders sold 4K and bought nothing on the open market.

All of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in Feb 2024.

Net open-market
−4K
0 buys · 2 sales
Under a 10b5-1 plan
100%
of the value sold
Insiders who bought / sold
0 / 2
executives and directors
Last open-market buy
Feb 2024
Feb 13, 2024

Get an email when BBOT's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Nov 1810b5-1 plan
    Pedro Beltran
    President and CEO · sold 1,870 at $1.84
    3K
    4.3% of stake
  • Nov 1310b5-1 plan
    Marc Cobo
    Principal Accounting Officer · sold 78 at $2.37
    $185
    0.6% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch BBOT, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with BBOT

CompareIntrinsic value
GANXGain Therapeutics Inc.
$1.00-4.86%25
KURAKura Oncology Inc.
$6.91-5.99%10
IRDOpus Genetics Inc.
$3.99-2.21%10
PVCTProvectus Biopharmaceuticals, Inc.
$0.05+1.11%6
VSTMVerastem Inc.
$6.33-7.73%40
LXRXLexicon Pharmaceuticals, Inc.
$1.53-8.38%40
COLLCollegium Pharmaceutical Inc.
$24.72-1.94%85
SVRASavara Inc.
$4.26-18.23%10

Held by ETFs

BBOT is in 7 US ETFs. The largest of them, with BBOT's weight in each:

Spot a number that looks wrong? Check it in BBOT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing BBOT

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.